Product Information
HUMIRA(CF) PEN PS-UV-ADOL HS START 80 MG/0.8 ML-40 MG/0.4 ML is a brand product labeled by AbbVie Inc., priced at $4441.4694 per EA under NDC 00074153903. Its NADAC has been published 100 times since Apr 17, 2024.
Manufacturer
AbbVie Inc.NDC
00074153903
Classification
Brand
Dosage Form
KIT
Last Updated
3/19/2025
Approval Type
Biologic (BLA)
FDA Application
BLA125057On Market Since
4/21/2017
Price Statistics
The NADAC for HUMIRA(CF) PEN PS-UV-ADOL HS START 80 MG/0.8 ML-40 MG/0.4 ML has been published 100 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $4441.4694 per EA |
|---|---|
| All-time high | $4462.4420 (Dec 11, 2024) |
| All-time low | $4441.4694 (Dec 18, 2024) |
| 52-week high | $4441.4694 |
| 52-week low | $4441.4694 |
| Median price | $4441.4694 |
| Average price | $4448.8098 |
| Largest weekly change | -0.5% (Dec 18, 2024) |
| Weeks tracked | 100 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 24% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of HUMIRA(CF) PEN PS-UV-ADOL HS START 80 MG/0.8 ML-40 MG/0.4 ML?
The current National Average Drug Acquisition Cost (NADAC) for HUMIRA(CF) PEN PS-UV-ADOL HS START 80 MG/0.8 ML-40 MG/0.4 ML, manufactured by AbbVie Inc., is $4441.4694 per EA (NDC 00074153903), effective Mar 11, 2026.
How has the price of HUMIRA(CF) PEN PS-UV-ADOL HS START 80 MG/0.8 ML-40 MG/0.4 ML changed over time?
Over the history we have for it, the NADAC for HUMIRA(CF) PEN PS-UV-ADOL HS START 80 MG/0.8 ML-40 MG/0.4 ML has held within roughly two percent of its current level. It has been tracked across 100 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for HUMIRA(CF) PEN PS-UV-ADOL HS START 80 MG/0.8 ML-40 MG/0.4 ML?
Since Apr 17, 2024, the NADAC for HUMIRA(CF) PEN PS-UV-ADOL HS START 80 MG/0.8 ML-40 MG/0.4 ML has ranged from a low of $4441.4694 (Dec 18, 2024) to a high of $4462.4420 (Dec 11, 2024), with a median of $4441.4694 per EA.
Are there cheaper alternatives to HUMIRA(CF) PEN PS-UV-ADOL HS START 80 MG/0.8 ML-40 MG/0.4 ML?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, HUMIRA(CF) 20 MG/0.2 ML SYRINGE, is $3366.1230 per EA — about 24% below HUMIRA(CF) PEN PS-UV-ADOL HS START 80 MG/0.8 ML-40 MG/0.4 ML.
Who manufactures HUMIRA(CF) PEN PS-UV-ADOL HS START 80 MG/0.8 ML-40 MG/0.4 ML?
HUMIRA(CF) PEN PS-UV-ADOL HS START 80 MG/0.8 ML-40 MG/0.4 ML (NDC 00074153903) is labeled by AbbVie Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification